Morganstern, Daniel Eric, MD
Hartford HealthCare Medical Group

Daniel Eric Morganstern, MD

Medical Oncology

Location Information

  • Hartford HealthCare Cancer Institute at Hartford Hospital
    85 Retreat Avenue
    Hartford, CT 06106

    860.249.6291

  • Hartford HealthCare Cancer Institute - Manchester
    376 Tolland Turnpike Suite 201
    Manchester, CT 06042

    860.533.5830

About Daniel Eric Morganstern, MD

  • Gender
    Male
  • Language
    English
  • Specialties
    Accepting New Patients

    Medical Oncology, Hematology / Oncology

    Not Currently Accepting New Patients

    Internal Medicine

  • Areas of Expertise
    Breast Cancer, Breast Cancer Genetics, Breast Cancer Prevention, Breast Cancer Research

Education

  • FellowshipBeth Israel Deaconess Medical Center

    InternshipNew England Deaconess Hospital

    Medical SchoolSUNY Brooklyn

    Research FellowshipHarvard Medical School

    ResidencyNew England Deaconess Hospital

  • Faculty Appointments

    Harvard University School of Medicine, Instructor

  • Professional Organizations

    Alliance Cancer Prevention Committee, Member
    Alliance for Clinical Trials in Oncology, Member

Bio

Dr. Daniel Morganstern is a hematologist/oncologist on the Hartford Hospital medical staff. He earned his medical degree from the State University of New York in Brooklyn, and completed a residency in internal medicine at New England Deaconess Hospital in Boston and a fellowship in hematology/oncology at Beth Israel Deaconess Medical Center in Boston. He also completed a clinical fellowship and research fellowship, both in medicine, at Harvard Medical School.

He has worked for years at Dana-Farber/Brigham and Women’s Cancer Center specializing in breast oncology where he was also co-director of medical oncology for the Breast Cancer Personalized Risk Assessment, Education and Prevention Clinic, which he co-founded. He was previously affiliated with Lahey Clinic in Boston as a researcher focused on prostate cancer, another hormonally driven disease.

Currently, he is a member of the Alliance Cancer Prevention Committee, Alliance for Clinical Trials in Oncology and an ad hoc reviewer for the publication Cancer Medicine. His research interests include breast cancer genetics and prevention strategies, metastatic breast cancer, the use of preoperative endocrine therapy in breast cancer patients and male breast cancer.

Back to Top